- Advertisement -

Related

Red October for Nordic CTAs, Stumble Into November

- Advertisement -

Stockholm (Hedgenordic) – As previously reported on Hedgenordic, October was doomed to be another challenging month for Nordic CTAs judging from the mid-month numbers available for funds with daily dealing. With October now behind us, one can conclude that it was indeed a red month for the industry and for Nordic managers alike.

The industry, as represented by the SG CTA Index, lost 2.8 percent on the month and was down 6.9 percent on the year as of November 1. The NHX CTA Index is yet to be updated for the month but early numbers for some of the reporting funds suggest dismal performance.

Industry heavyweight Lynx was down 3.6 percent in its main fund, translating into a 4.2 percent drop for the year. According to the manager´s monthly report, losses stemmed from stock indices and commodities where both energies and soft commodities contributed to losses. The manager further writes that the downturn in equity markets made models turn overall equity exposure short going into November.

SEB Asset Selection lost more than 1 percent on the month, presumably doing relatively well due to no exposure in the commodity sector. On the year however, the fund had lost 8 percent by the end of October, according to estimates.

RPM’s two funds RPM Evolving CTA Fund and RPM Galaxy were both down on the month, the latter posting a whopping 18 percent drop for the period (-25% on the year). In the case of Evolving, the monthly loss was more in line with the industry and the fund was still up for the year by end October.

Among exceptions was the Alfa Axiom fund from Alfakraft, a program that is using shorter term trend models. Axiom gained 1.3 percent on the month and was up 0.6 percent on the year as per October 31.

As if the difficult market conditions for systematic trend followers in October was not enough, the first trading day of November apparently has put more pressure on the strategy. Data from Avanza suggest that Lynx lost 3.8 percent on November 1, SEB Asset Selection dropped 1.8 percent and Alfa Axiom posted a 1.7 percent loss. On its website, RPM suggest a loss of 3.8 percent for Evolving and an additional 5.8 percent drop for Galaxy on the first trading day of November.

Picture (c): IndianSummer—shutterstock_109471070

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

HedgeNordic Editorial Team
HedgeNordic Editorial Team
This article was written, or published, by a member of the HedgeNordic editorial team.

Latest Articles

Alcur Elevates Flöstrand to CIO One Year After Joining

Stock-picking boutique Alcur Fonder has appointed Per Flöstrand as Chief Investment Officer, with the portfolio manager taking over the role from co-founder and long-time...

Month in Review – March 2026

After a solid start to 2026, following three consecutive years of strong performance, March proved to be a sharp setback for Nordic hedge funds....

Archipelago Adds Firepower After Back-to-Back Strong Years

Archipelago Investments is strengthening its investment team with the appointment of Anders Fagerlund as Senior Analyst and Head of Research. Bringing 15 years of...

From Zero Rates to Volatility: Excalibur at 25

Around the same time last year, Lynx Asset Management marked the 25-year anniversary of its flagship strategy. This April, it is Excalibur Asset Management’s...

Two Allocators, One View: Liquidity, Cost and Control Behind CTA ETF Adoption

On the surface, Morten Christensen, Chief Financial Officer at Norwegian family office Aars, and Jonas Thulin, Chief Investment Officer at Sweden’s AP3, may appear...

Maybe CTA Alpha is Simpler Than You Think: Evidence from the ETF Space

By Andrew Beer, Co-Founder of DBi: Managers of CTA hedge funds and mutual funds often argue that complexity leads to higher alpha generation. After all, why...

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -